Kalaris Therapeutics, Inc. - Common StockShare · US4829291065 · KLRS (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Kalaris Therapeutics, Inc. - Common Stock
No Price
01.05.2026 20:02
Current Prices from Kalaris Therapeutics, Inc. - Common Stock
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
KLRS
USD
01.05.2026 20:02
5,40 USD
-0,12 USD
-2,17 %
IEX
KLRS
USD
01.05.2026 19:20
5,49 USD
-0,03 USD
-0,54 %
Share Float & Liquidity
Free Float21,50 %
Shares Float4,02 M
Shares Outstanding18,7 M
Company Profile for Kalaris Therapeutics, Inc. - Common Stock Share
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
